หน้าแรก
ค้นหา
Dr. Biran Discusses Doublets Versus Triplets in Myeloma
No description available
แสดงข้อมูลเพิ่มเติม 1
IMF Patient & Family Webinar 2023 - Understanding The New Myeloma Landscape - Eastern
Best of 2021 ASCO & EHA Webinar
Should myeloma patients undergo genetic testing to determine their best treatment options?
IMF Patient & Family Webinar - Understanding The New Myeloma Landscape
Adapting Clinical Practice to a Rapidly Changing Therapeutic Landscape in Multiple Myeloma
Living Well with Myeloma: Sorting Out the Approach to Relapse
What treatment is recommended for a newly diagnosed patient?
New Strategies for Multiple Myeloma Care: Next Steps to the Future
MCRT St. Louis 2018: Expert Panel Q&A: Multiple Myeloma (Morning Session)
IMF Patient & Family Webinar 2023 - Understanding The New Myeloma Landscape
What is isatuximab? And how does it compare with daratumumab?
What is the status of Empliciti® (elotuzumab), the new immunotherapy?
IMF Patient & Family Webinar - Back to Basics: From Testing to Tailored Therapy
Race Matters in Myeloma Care & Survival
Pomalidomide + Low-Dose Dex + Dara in Relapsed and/or Refractory Multiple Myeloma
Expert Perspectives: Myeloma
Proposed 2019 treatment algorithms for MM
Analysis of the Randomized Forte Trial in Newly Diagnosed Multiple Myeloma
Dara‐Vrd Vs. Vrd in Pts with Newly Diagnosed Myeloma Eligible for ASCT
Tandem Transplant and Combined Infusion of CD19 and BCMA-Specific CAR T-Cells for HRMM
